Visit our CLL Information and Resource CentreA guide for patients looking for answers to their CLL questions on the Internet. |
Understanding your preferred communication style can significantly enhance your relationship with your healthcare team and empower you to make informed decisions about your health.
The development of a new cancer drug at the University of Alberta shows both the promise and the challenges of drug development.
There is some good news to share on the treatment front! Since spring 2025, six provinces in Canada have made publicly funded Ibrutinib + Venetoclax (I+V) combination therapy available for previously untreated CLL patients.
